The DAS28-CRP is a composite measure used to assess disease activity in RA.
Medically reviewed by Dr. Rao Khurram Ayoub, RPh, PhD (Pharmaceutics)
Written by Dr. Muhammad Imran, M.Phil, PharmD, BSc
Updated on
| Current DAS28 | ΔDAS28 > 1.2 | ΔDAS28 0.6 – 1.2 | ΔDAS28 ≤ 0.6 |
|---|---|---|---|
| ≤ 3.2 (Remission/Low) | Good | Moderate | None |
| 3.2 – 5.1 (Moderate) | Moderate | Moderate | None |
| > 5.1 (High) | Moderate | None | None |
The DAS28-CRP is a composite measure used to assess disease activity in RA.
The DAS28-CRP is calculated using the following validated formula:
| Component | Variable | Description |
|---|---|---|
| TJC28 | Tender Joint Count | Number of tender joints out of 28 assessed (0–28) |
| SJC28 | Swollen Joint Count | Number of swollen joints out of 28 assessed (0–28) |
| CRP | C-Reactive Protein | Acute phase reactant; entered in mg/L (the calculator converts from mg/dL if needed) |
| GH | Patient Global Health | Patient’s overall assessment on a 0–100 mm VAS |
Real-Time Tracking: The Disease Activity Score (DAS) measures how active a patient’s rheumatoid arthritis is at any given moment, allowing clinicians to trend inflammation over time.
Clinical Evolution: Originally engineered to evaluate drug efficacy in clinical trials, DAS has now become the standard real-world marker for day-to-day disease monitoring.
Treat-to-Target Strategy: Modern protocols mandate calculating DAS frequently to guide treatment adjustments until a patient achieves clinical remission or reaches safe target ESR/CRP laboratory levels.
Streamlined Assessment: The scoring system was simplified from its original 44-joint count down to 28 joints (DAS28) to make routine examinations faster and more practical.
Inter-Rater Variability: Because physical joint exams rely on touch, different clinicians may grade swelling or tenderness slightly differently, creating minor variations in scores.
The Foot Omission: DAS28 intentionally excludes the feet because walking puts mechanical stress on those joints, which can mimic arthritis pain. However, foot issues must still be assessed holistically and managed as part of comprehensive patient care.
Matsui, T., et al. (2003) Annual Report of the National Hospital Organization, pp. 21-24.
Fleischmann, R., et al. (2016) Annals of the Rheumatic Diseases, 74, pp. 1132-1137.
Korea University (2025) Korean Journal of Internal Medicine [Meta-analysis].
Riley, T.R., et al. (2025) Rheumatology, 64(6), pp. 3921-3928.